Keystone Financial Group - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Keystone Financial Group ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$21,884
-39.2%
24,700
+9.1%
0.00%
-42.9%
Q3 2022$36,000
-21.7%
22,6500.0%0.01%
-22.2%
Q2 2022$46,000
-2.1%
22,650
+12.4%
0.01%
+12.5%
Q1 2022$47,000
-44.0%
20,150
+11.0%
0.01%
-42.9%
Q4 2021$84,000
-35.9%
18,150
+5.8%
0.01%
-41.7%
Q3 2021$131,000
-20.6%
17,150
+0.6%
0.02%
-20.0%
Q2 2021$165,000
+17.0%
17,0500.0%0.03%
+11.1%
Q1 2021$141,000
+29.4%
17,050
+6.8%
0.03%
+17.4%
Q4 2020$109,00015,9700.02%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Paloma Partners Management Co 3,775,000$1,359,0000.05%
Oaktree Fund Advisors, LLC 66,000$23,7600.02%
GoalVest Advisory LLC 32,915$11,8490.01%
Houlihan Financial Resource Group, Ltd. 30,000$110.01%
Granite Bay Wealth Management, LLC 22,520$80.01%
S&T BANK/PA 38,853$140.00%
Lattice Capital Management, LLC 51,800$18,6480.00%
Modus Advisors, LLC 19,706$7,0940.00%
Crescent Grove Advisors, LLC 60,000$21,6000.00%
SlateStone Wealth, LLC 21,433$80.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders